Back to Market Feed

Product Information

BRIVIACT 10 MG/ML ORAL SOLN is a brand product labeled by UCB, Inc., priced at $4.8099 per ML under NDC 50474087015. Its NADAC has been published 359 times since Nov 20, 2019.

FDA first approved this application on May 12, 2016. Its Orange Book therapeutic-equivalence code is AA.

BRIVIACT 10 MG/ML ORAL SOLN

brivaracetam
$4.8099per ML
DEA Schedule CV

Strength

10 mg/mL

Manufacturer

UCB, Inc.

NDC

50474087015

Classification

Brand

Dosage Form

SOLUTION

Route

ORAL

Effective Date

9/23/2026

Active Ingredients

BRIVARACETAM

Approval Type

New Drug (NDA)

FDA Application

NDA205838

FDA Approved

5/12/2016

TE Code

AA

On Market Since

5/12/2016

Pharmacological Classes

Epoxide Hydrolase Inhibitors

Price Statistics

The NADAC for BRIVIACT 10 MG/ML ORAL SOLN has been published 359 times since Nov 20, 2019, and over the history we have for it it has risen 32.3%. The table below summarizes its recorded NADAC range and movement.

Current price$4.8099 per ML
All-time high$4.8191 (May 13, 2026)
All-time low$3.6358 (Nov 20, 2019)
52-week high$4.8191
52-week low$4.6959
Median price$4.3906
Average price$4.2903
Largest weekly change+6.9% (Jan 12, 2022)
Weeks tracked359
Tracking sinceNov 20, 2019

Price History

1W

0.0%

1M

+0.0%

3M

+0.0%

6M

-0.2%

1Y

+2.4%

3Y

+9.6%

5Y

+24.2%

All

+32.3%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the brivaracetam market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

No related drugs found.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Manufacturer

UCB, Inc. manufacturer profile

See the full portfolio, pricing trend, and other products from this labeler.

Drug market

brivaracetam market comparison

Compare this molecule across participating manufacturers and inspect the broader market price spread.

Trend hub

Latest market trends

Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.

Guide

Understanding NADAC pricing

Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.

Frequently asked questions

What is the NADAC price of BRIVIACT 10 MG/ML ORAL SOLN?

The current National Average Drug Acquisition Cost (NADAC) for BRIVIACT 10 MG/ML ORAL SOLN, manufactured by UCB, Inc., is $4.8099 per ML (NDC 50474087015), effective Sep 30, 2026.

How has the price of BRIVIACT 10 MG/ML ORAL SOLN changed over time?

Over the history we have for it, the NADAC for BRIVIACT 10 MG/ML ORAL SOLN has risen 32.3%. It has been tracked across 359 weekly CMS publications since Nov 20, 2019.

What are the highest and lowest recorded NADAC prices for BRIVIACT 10 MG/ML ORAL SOLN?

Since Nov 20, 2019, the NADAC for BRIVIACT 10 MG/ML ORAL SOLN has ranged from a low of $3.6358 (Nov 20, 2019) to a high of $4.8191 (May 13, 2026), with a median of $4.3906 per ML.

Are there cheaper alternatives to BRIVIACT 10 MG/ML ORAL SOLN?

No other NADAC-published product currently shares the active ingredient and strength of BRIVIACT 10 MG/ML ORAL SOLN in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures BRIVIACT 10 MG/ML ORAL SOLN?

BRIVIACT 10 MG/ML ORAL SOLN (NDC 50474087015) is labeled by UCB, Inc., and CMS classifies it as a brand product.